Literature DB >> 22994581

A survey on blood pressure levels and hypertension control in a sample of the Italian general population.

Marco De Giusti1, Eleonora Dito, Beniamino Pagliaro, Simone Burocchi, Flora Ilaria Laurino, Giuliano Tocci, Massimo Volpe, Speranza Rubattu.   

Abstract

BACKGROUND: Hypertension represents a major cardiovascular risk factor with relevant consequences on morbidity and mortality in the general population. An optimal control of blood pressure (BP) is far from being achieved. AIM: The objective of this study was to explore awareness of BP levels, prevalence of risk factors and status of hypertension control in a sample of the Italian general population.
METHODS: Subjects aged 18 years or older were enrolled on a voluntary basis during the 7th and 8th World Hypertension Days at our hospital centre, S. Andrea Hospital in Rome, and at other hospitals throughout the Italian Lazio region. Along with BP measurement, a short questionnaire was completed at the time of the interview.
RESULTS: Of 1165 individuals enrolled into the analysis, 71.7% were aware of their BP levels (82.5% among hypertensive patients). Within the whole cohort, 31.9% of subjects were under antihypertensive treatment, while the overall rate of subjects found to be hypertensive patients at our visit was 52.9% (n = 616). Among hypertensive patients taking antihypertensive drugs, 47.1% had controlled BP values with the remaining 52.9% showing uncontrolled hypertension. Mean systolic blood pressure (SBP) was 138.2 ± 20.7 mmHg and mean diastolic blood pressure (DBP) was 80.4 ± 11.3 mmHg in subjects receiving antihypertensive treatment. Among older hypertensive patients (71-94 years of age), only 76.9% were under treatment. Hypertensive males were more frequently treated than females in all age groups (p = 0.001). Smoking habit negatively affected efficacy of antihypertensive therapy in the age groups of 48-53 and 54-62 years (p = 0.008 and p = 0.01, respectively). Diabetic patients had higher mean SBP values than non-diabetic subjects (137.3 ± 22.1 vs 129.3 ± 18.2 mmHg, p = 0.02).
CONCLUSION: The results of our survey strongly support the need for a continuing educational effort aimed at providing correct advertisement of healthy lifestyles and awareness of adequate BP control. Based on our observations, particular attention has to be paid to women, younger subjects, elderly subjects and diabetic patients in order to reach appropriate BP control and reduction of cardiovascular risk in these subject categories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994581     DOI: 10.2165/11632190-000000000-00000

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  21 in total

1.  Hypertension in adults across the age spectrum: current outcomes and control in the community.

Authors:  Donald M Lloyd-Jones; Jane C Evans; Daniel Levy
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  Gender-related differences in the management of hypertension by cardiologists: the PARITE study.

Authors:  Claire Mounier-Vehier; Tabassome Simon; Dominique Guedj-Meynier; Marc Ferrini; Emmanuel Ghannad; Jean-Pierre Hubermann; Gérard Jullien; Pascal Poncelet; Assya Achouba; Stéphane Quéré; Maxime Guenoun
Journal:  Arch Cardiovasc Dis       Date:  2012-05-23       Impact factor: 2.340

4.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

5.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04

6.  Blood pressure control in Italy: results of recent surveys on hypertension.

Authors:  Massimo Volpe; Giuliano Tocci; Bruno Trimarco; Enrico Agabiti Rosei; Claudio Borghi; Ettore Ambrosioni; Alessandro Menotti; Alberto Zanchetti; Giuseppe Mancia
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

7.  Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.

Authors:  Julie A Schmittdiel; Connie S Uratsu; Andrew J Karter; Michele Heisler; Usha Subramanian; Carol M Mangione; Joe V Selby
Journal:  J Gen Intern Med       Date:  2008-03-04       Impact factor: 5.128

8.  Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients.

Authors:  S Freestone; L E Ramsay
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965

Review 9.  Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension.

Authors:  Giuliano Tocci; Enrico Agabiti Rosei; Ettore Ambrosioni; Claudio Borghi; Claudio Ferri; Andrea Ferrucci; Giuseppe Mancia; Alberto Morganti; Roberto Pontremoli; Bruno Trimarco; Alberto Zanchetti; Massimo Volpe
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  9 in total

1.  Renin-angiotensin-aldosterone system blockade is safe and effective in elderly hypertensive patients with and without impaired renal function.

Authors:  Claudio Ferri; Livia Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2012-12

2.  Clinical management of patients with hypertension and high cardiovascular risk: main results of an Italian survey on blood pressure control.

Authors:  Giuliano Tocci; Claudio Borghi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-10-23

3.  Attitudes and preferences for the clinical management of patients with hypertension and hypertension with chronic obstructive pulmonary disease in Italy: main results of a survey questionnaire.

Authors:  Giuliano Tocci; Arrigo F Cicero; Massimo Salvetti; Jasmine Passerini; Maria Beatrice Musumeci; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  Intern Emerg Med       Date:  2015-05-19       Impact factor: 3.397

4.  Attitudes and preferences for the clinical management of hypertension and hypertension-related cardiac disease in general practice: results of the Italian Hypertension and Heart Survey.

Authors:  G Tocci; A F Cicero; M Salvetti; P Francia; A Ferrucci; C Borghi; M Volpe
Journal:  J Hum Hypertens       Date:  2014-12-18       Impact factor: 3.012

5.  Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.

Authors:  F Galletti; A Barbato
Journal:  J Hum Hypertens       Date:  2016-03-03       Impact factor: 3.012

Review 6.  Hypertension in premenopausal women: is there any difference?

Authors:  Andrea Ferrucci; Giulia Pignatelli; Sebastiano Sciarretta; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-04-03

7.  Long term trends in control of hypertension in the Northern Sweden MONICA study 1986-2009.

Authors:  Ellinor Törmä; Bo Carlberg; Marie Eriksson; Jan-Håkan Jansson; Mats Eliasson
Journal:  BMC Public Health       Date:  2015-09-24       Impact factor: 3.295

8.  Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting.

Authors:  Luca Degli Esposti; Stefania Saragoni; Stefano Buda; Ezio Degli Esposti
Journal:  Clinicoecon Outcomes Res       Date:  2014-04-22

9.  7th Brazilian Guideline of Arterial Hypertension: Chapter 6 - Non-pharmacological treatment

Authors:  M V B Malachias; R J S Franco; C L M Forjaz; A M G Pierin; M M G Gowdak; M R S T Klein; V Matsudo
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.